HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rémi Favier Selected Research

src-Family Kinases

3/2016A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rémi Favier Research Topics

Disease

5Thrombocytopenia (Thrombopenia)
01/2020 - 03/2012
5Hemorrhage
11/2018 - 03/2012
4Thrombosis (Thrombus)
01/2020 - 01/2010
3Gray Platelet Syndrome
02/2023 - 01/2018
3Neoplasms (Cancer)
12/2021 - 09/2012
3Primary Myelofibrosis (Myelosclerosis)
05/2020 - 03/2016
2Thrombocytosis (Thrombocythemia)
01/2017 - 02/2014
2Vascular System Injuries
07/2015 - 09/2009
2Renal Insufficiency (Renal Failure)
03/2012 - 03/2005
2Anemia
03/2012 - 01/2006
2Proteinuria
03/2012 - 03/2005
1Autoimmune Diseases (Autoimmune Disease)
01/2023
1Bronchiolitis Obliterans Syndrome
05/2020
1Splenomegaly
05/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019
1Leukemia
11/2018
1Ectopic Pregnancy
11/2018
1Fibrosis (Cirrhosis)
01/2018
1Bernard-Soulier Syndrome (Giant Platelet Syndrome)
09/2014
1Essential Thrombocythemia
02/2014
1Jacobsen Distal 11q Deletion Syndrome
09/2012
1Hematuria
03/2012
1Lymphopenia (Lymphocytopenia)
03/2012
1Hypoprothrombinemias (Prothrombin Deficiency)
03/2012
1Pre-Eclampsia (Preeclampsia)
09/2009
1Type 2 von Willebrand Disease
02/2003

Drug/Important Bio-Agent (IBA)

3von Willebrand FactorIBA
02/2023 - 02/2003
3CollagenIBA
11/2018 - 01/2010
3Proteins (Proteins, Gene)FDA Link
01/2018 - 09/2012
2SteroidsIBA
05/2020 - 03/2012
2Prothrombin (Factor II)IBA
01/2020 - 03/2012
2Thrombopoietin (c-mpl Ligand)IBA
01/2017 - 02/2014
1CalreticulinIBA
12/2021
1Thrombopoietin ReceptorsIBA
12/2021
1Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2020
1ruxolitinibIBA
05/2020
1Fibrinogen (Factor I)FDA Link
01/2020
1KaolinIBA
01/2020
1Collagen ReceptorsIBA
01/2019
1LigandsIBA
11/2018
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2018
1convulxinIBA
11/2018
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
11/2018
1EphrinsIBA
11/2018
1Tranexamic Acid (AMCA)FDA Link
11/2018
1Tyrosine (L-Tyrosine)FDA Link
01/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1src-Family KinasesIBA
03/2016
1FibrinIBA
07/2015
1Phosphotransferases (Kinase)IBA
02/2014
1Glycoproteins (Glycoprotein)IBA
01/2013
1Transcription Factors (Transcription Factor)IBA
09/2012
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
03/2012
1Intravenous Immunoglobulins (IVIG)FDA Link
03/2012
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2012
1ThrombomodulinIBA
09/2009
1Phospholipids (Phosphatides)FDA LinkGeneric
09/2009
1Biomarkers (Surrogate Marker)IBA
09/2009
1Thromboplastin (Tissue Factor)IBA
09/2009
1AntigensIBA
09/2009
1hemoglobin CalaisIBA
01/2006
1Hemoglobins (Hemoglobin)IBA
01/2006
1HaptoglobinsIBA
03/2005
1Factor VIII (Coagulation Factor VIII)IBA
02/2003

Therapy/Procedure

2Therapeutics
01/2023 - 03/2012
1Stem Cell Transplantation
05/2020
1Tooth Extraction (Tooth Extractions)
03/2012